Literature DB >> 17996450

2D QSAR and similarity studies on cruzain inhibitors aimed at improving selectivity over cathepsin L.

Renato F Freitas1, Tudor I Oprea, Carlos A Montanari.   

Abstract

Hologram quantitative structure-activity relationships (HQSAR) were applied to a data set of 41 cruzain inhibitors. The best HQSAR model (Q(2)=0.77; R(2)=0.90) employing Surflex-Sim, as training and test sets generator, was obtained using atoms, bonds, and connections as fragment distinctions and 4-7 as fragment size. This model was then used to predict the potencies of 12 test set compounds, giving satisfactory predictive R(2) value of 0.88. The contribution maps obtained from the best HQSAR model are in agreement with the biological activities of the study compounds. The Trypanosoma cruzi cruzain shares high similarity with the mammalian homolog cathepsin L. The selectivity toward cruzain was checked by a database of 123 compounds, which corresponds to the 41 cruzain inhibitors used in the HQSAR model development plus 82 cathepsin L inhibitors. We screened these compounds by ROCS (Rapid Overlay of Chemical Structures), a Gaussian-shape volume overlap filter that can rapidly identify shapes that match the query molecule. Remarkably, ROCS was able to rank the first 37 hits as being only cruzain inhibitors. In addition, the area under the curve (AUC) obtained with ROCS was 0.96, indicating that the method was very efficient to distinguishing between cruzain and cathepsin L inhibitors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17996450     DOI: 10.1016/j.bmc.2007.10.048

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  8 in total

1.  Computation of 3D queries for ROCS based virtual screens.

Authors:  Gregory J Tawa; J Christian Baber; Christine Humblet
Journal:  J Comput Aided Mol Des       Date:  2009-09-26       Impact factor: 3.686

2.  Shape similarity guided pose prediction: lessons from D3R Grand Challenge 3.

Authors:  Ashutosh Kumar; Kam Y J Zhang
Journal:  J Comput Aided Mol Des       Date:  2018-08-06       Impact factor: 3.686

3.  Development of a pharmacophore for cruzain using oxadiazoles as virtual molecular probes: quantitative structure-activity relationship studies.

Authors:  Anacleto S de Souza; Marcelo T de Oliveira; Adriano D Andricopulo
Journal:  J Comput Aided Mol Des       Date:  2017-08-09       Impact factor: 3.686

Review 4.  The importance of discerning shape in molecular pharmacology.

Authors:  Sandhya Kortagere; Matthew D Krasowski; Sean Ekins
Journal:  Trends Pharmacol Sci       Date:  2009-01-31       Impact factor: 14.819

5.  In silico approach to screen compounds active against parasitic nematodes of major socio-economic importance.

Authors:  Varun Khanna; Shoba Ranganathan
Journal:  BMC Bioinformatics       Date:  2011-11-30       Impact factor: 3.169

6.  Non-peptidic cruzain inhibitors with trypanocidal activity discovered by virtual screening and in vitro assay.

Authors:  Helton J Wiggers; Josmar R Rocha; William B Fernandes; Renata Sesti-Costa; Zumira A Carneiro; Juliana Cheleski; Albérico B F da Silva; Luiz Juliano; Maria H S Cezari; João S Silva; James H McKerrow; Carlos A Montanari
Journal:  PLoS Negl Trop Dis       Date:  2013-08-22

7.  Hologram QSAR models of 4-[(diethylamino)methyl]-phenol inhibitors of acetyl/butyrylcholinesterase enzymes as potential anti-Alzheimer agents.

Authors:  Simone Decembrino de Souza; Alessandra Mendonça Teles de Souza; Ana Carolina Corrêa de Sousa; Ana Carolina Rennó Sodero; Lúcio Mendes Cabral; Magaly Girão Albuquerque; Helena Carla Castro; Carlos Rangel Rodrigues
Journal:  Molecules       Date:  2012-08-09       Impact factor: 4.411

Review 8.  Advances in the Development of Shape Similarity Methods and Their Application in Drug Discovery.

Authors:  Ashutosh Kumar; Kam Y J Zhang
Journal:  Front Chem       Date:  2018-07-25       Impact factor: 5.221

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.